Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 14667299

Molecular bioelectronics.

J J Davis
View original source ↗Export metadata ↓

Abstract

Biological macromolecules have evolved over many millions of years into structures primed, in some cases, for both specific surface recognition and facile, directional electron tunnelling. The redox-active centres of metalloproteins play a central role in photosynthesis and respiration. The processes by which constructive man-made interfaces to these moieties can be generated have advanced greatly during the past two decades or so. Together with recent advances in molecular manipulation, analyses and lithographic fabrication, this knowledge has led to us to the point where bioelectronic devices can be designed and interrogated with good levels of reproducibility.

Explore related subjects

BiopolymersBiosensing TechniquesComputers, MolecularElectrochemistryElectronicsMetalloproteinsMicroelectrodesSemiconductorsTransducersJournal ArticleResearch Support, Non-U.S. Gov'tReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J Davis. 2003-12-15. Molecular bioelectronics.. https://doi.org/10.1098/rsta.2003.1270

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2004

Crystallization of oxytetracycline from fermentation waste liquor: influence of biopolymer impurities.

Organic impurities in the fermentation broth of antibiotic production impose great difficulties in the crystallization and recovery of antibiotics from the concentrated waste liquor. In the present laboratory study, the inhibitory effect of biopolymers on antibiotic crystallization was investigated using oxytetracycline (OTC) as the model antibiotic. Organic impurities separated from actual OTC fermentation waste liquor by ultrafiltration were dosed into a pure OTC solution at various concentrations. The results demonstrated that small organic molecules with an apparent molecular weight (AMW) of below 10,000 Da did not affect OTC crystallization significantly. However, large biopolymers, especially polysaccharides, in the fermentation waste caused severe retardation of crystal growth and considerable deterioration in the purity of the OTC crystallized. Atomic force microscopy (AFM) revealed that OTC nuclei formed in the solution attached to the surfaces of large organic molecules, probably polysaccharides, instead of being surrounded by proteins as previously thought. It is proposed that the attachment of OTC nuclei to biopolymers would prevent OTC from rapid crystallization, resulting in a high OTC residue in the aqueous phase. In addition, the adsorption of OTC clusters onto biopolymers would destabilize the colloidal system of organic macromolecules and promote particle flocculation. OTC crystallization would therefore take place with the precipitation of abundant organic impurities. Hence, the removal of polysaccharides and other biopolymers by ultrafiltration can be an effective means of improving the recovery of OTC and similar antibiotics by crystallization from the fermentation waste.

Biopolymers↗
PubMed2004

Synthesis of low-shrinkage polymerizable liquid-crystal monomers.

Polymerization shrinkage remains a major barrier to the universal use of resin restorative in large posterior cavity preparations. A new bifunctional liquid crystal (LC) monomer, 2-(t-butyl), 1,4-bis-[4-(6-acryloxy-hexane-1-oxy)-benzoyloxy] benzene, with exceptionally low polymerization shrinkage, has recently been discovered. The purpose of this communication is to report a new, easy, high-yield synthetic route to synthesize this compound in comfortable larger batches. Synthetic and isolation details, chemical characteristics, and the polymerizable properties of a new structurally related by-product monomer, namely, 2-(t-butyl),1-[4-(6-acryloxy-hexane-1-oxy)-benzoyloxy], 4-[4-[6-(3-acryl oxy-propionoxy)-hexane-1-oxy]-benzoyloxy]-benzene, is also reported. The structural confirmation of this by-product indicates that it resulted from the Michael-type addition of acrylate ion on one of the terminal acryloxy groups of 2-(t-butyl), 1,4-bis-[4-(6-acryloxy-hexane-1-oxy)-benzoyloxy] benzene. The by-product itself, as well as the natural blend of the aforesaid both products as formed in the reaction mixture, also polymerized at room temperature with lesser volume shrinkage as compared to the conventional control (GTE) at similar degrees of conversion.

Biopolymers↗